The pharmaceutical industry is facing a host of massive changes. Laboratory advances have opened the door to treating a potentially vast number of diseases and conditions. At the same time, many so-called "blockbuster" drugs are coming off patent. As a result, executives feel increasing pressure to invest in R&D capabilities that will turn scientific breakthroughs into new products. Merger and acquisition activity has accelerated as companies seek larger portfolios of research programs and greater economies of scale. High-visibility marketing and sales campaigns have stimulated demand, encouraging the public to think of pharmaceuticals as branded consumer products. Meanwhile, high margins and costs have attracted the attention of government regulators and employers alike. They worry that the push for bottom-line results has sidelined important issues like drug safety and affordability.

CFAR has many tools and methods to help pharmaceutical companies respond to these trends. We provide support for:

• Building alliances and partnerships in rapidly-changing markets.
• Developing strategy at the business unit and corporate level.
• Improving productivity in the laboratory and at clinical trials sites.
• Adapting marketing plans to respond to the shifting dynamics of payers, providers and consumers.
• Managing change during times of reorganization and realignment.